Company Quick10K Filing
Reva Medical
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-08-06 Enter Agreement, Off-BS Arrangement, Other Events, Exhibits
8-K 2019-04-02 Enter Agreement, Off-BS Arrangement, Other Events, Exhibits
8-K 2019-03-29 Officers, Other Events, Exhibits
8-K 2019-03-12 Other Events, Exhibits
8-K 2019-03-05 Other Events, Exhibits
8-K 2019-02-25 Other Events, Exhibits
8-K 2019-02-19 Other Events, Exhibits
8-K 2019-02-17 Other Events, Exhibits
8-K 2019-02-04 Exit Costs, Exhibits
8-K 2019-01-14 Officers, Exhibits
8-K 2019-01-02 Officers, Exhibits
8-K 2018-11-14 Regulation FD, Exhibits
8-K 2018-11-05 Officers
8-K 2018-11-05 Earnings, Exhibits
8-K 2018-09-22 Regulation FD, Exhibits
8-K 2018-08-07 Earnings, Exhibits
8-K 2018-07-30 Earnings, Exhibits
8-K 2018-07-30 Enter Agreement, Exhibits
8-K 2018-07-25 Other Events, Exhibits
8-K 2018-06-26 Regulation FD, Exhibits
8-K 2018-05-23 Regulation FD, Exhibits
8-K 2018-05-16 Shareholder Vote
8-K 2018-03-22 Officers
8-K 2018-03-13 Regulation FD, Exhibits
8-K 2018-02-28 Earnings, Regulation FD, Exhibits
8-K 2018-02-05 Officers, Exhibits
8-K 2018-01-08 Regulation FD, Exhibits

Reva Medical Financials

-

RVA Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Apollo Education (APOL) 1,063,295 1,955,243 886,324 2,000,328 0 -19,719 98,213 579,272
China Crawfish (CACA) 2 0 0 0 -4 -4 -3
Mirenco (MREO)
Weyland Tech (WEYL) 10,602 5,280 29,462 -958 -4,242 -4,099 -5,303
Lingo Media (LMDC) 1,302 743 0 0 0 0 -0
Granite Real Estate (GRP)
Wewin Group (WWIN) 26 114 5 20 -95 -95 -20
MWF Global (MWF) 0 0 -34 -34 -1
Frontier Digital Media Group (FDMG) 5 31 32 0 -29 -29 -3
Brighthouse Life Insurance Co of Ny (BHNY) 9,065,749 8,029,864 236,819 0 0 2,514 -190,199
G-Mes Holdings (GMES) 1,262 812 652 609 67 141 -31
Baynon (BNON) 11 145 0 0 -21 -20 99
Immune Therapeutics (IMUN) 0 24 12,553 0 34 -5,080 -5,079 -21
Green Planet Bio Engineering (GPLB) 3,001 0 272 0 0 -38 -38 3,001
Blue Sphere (BLSP) 894 43,956 86,868 7,950 2,700 -14,453 -14,295 8,802
Therapeutic Solutions (TSOI) 0 367 1,851 13 10 -1,579 -1,236 481
Stem Holdings (STEMH) 40,803 5,703 958 364 -8,070 -7,496 -5,454
SpringWorks (SWTX)
Clean Coal Technologies (CCTC) 27 16,749 0 0 -5,795 -3,052 894
Ryanair Holdings (RYAA) 13,250,700 8,035,800 0 0 0 0 -34,900

Balance Sheet ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash59,16154,57449,54744,33738,87636,03531,02225,96619,22913,0328,9796,29725,81420,58315,88111,84516,89522,07316,54911,5536,6741,71029,14724,10020,00014,90010,9007,094
Accounts Receivable65636984115
Inventory506370627945860831
PP&E1,9602,7595,8716,0246,2236,4167,0707,5337,8577,9538,0028,0468,1968,4678,5998,8758,9889,1639,4059,5719,6719,0399,1799,3018,7288,7819,3879,528
Assets67,32062,54057,56752,61847,39741,76136,70631,05724,78517,86113,3119,93930,19524,93020,19915,57620,07125,14119,47114,2699,4834,26832,07126,68322,66118,60114,53710,626
Accounts Payable1,2848429876496566491,1361,1211,4008807026236516328757111,0541,3138278837787539493637568491,0701,010
Long-Term Debt
Liabilities2,7372,4992,6292,5812,7712,4843,0313,5503,9603,0002,2412,45856,64474,12162,70491,807100,635105,314102,311120,36899,07691,525131,347120,699115,47486,89779,65983,896
Stockholders' Equity64,58360,04154,93850,03744,62639,27733,67527,50720,82514,86111,0707,481-26,449-49,191-42,505-76,231-80,564-80,173-82,840-106,099-89,593-87,257-99,276-94,016-92,813-68,296-65,122-73,270
Income Statement ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue1728539193
Cost of Revenue73556121141
Gross Profit10-7-3-30-48
R&D3,7994,0243,9284,1974,5825,0885,3454,8792,9732,9303,5363,2644,0674,4045,0255,2884,6654,2124,0063,9643,0833,0922,6212,4352,5051,729
SG&A1,9771,6872,8063,2943,1352,821
Tax000000000000000000
Net Income-5,698-5,915-5,834-6,329-6,331-6,647-7,191-7,753-7,276-4,833-4,397-34,531-23,3575,854-34,868-30,223-40,798-4,555-23,94315,1981,424-5036,05316023,3431,927-9,036
Cash Flow ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating-4,549-4,199-4,574-5,380-3,512
Cash Investing-347-828-6482,539467
Cash Financing3091120